Year in Review 2024-2025: Cutting-Edge Research on SGLT2 Inhibitors
Why Another Update? Once confined to glycemic control in type 2 diabetes, sodium-glucose co-transporter 2 (SGLT2) inhibitors have firmly entrenched themselves as foundational agents in